A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...
A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials ...
ImmunityBio has gained US Food and Drug Administration (FDA) authorisation for an expanded access programme to supply an ...
ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the U.S. Food and Drug Administration (FDA ...
The FDA has authorized ImmunityBio’s expanded access program to bring alternative sources of the cancer-fighting bacteria BCG ...
ImmunityBio (IBRX) announced the U.S. Food and Drug Administration FDA has authorized an expanded access program EAP that will bring a vital ...
FDA approves an expanded access program that would offer patients an alternative to Merck’s bladder cancer medication.
A landmark review in Molecular Biomedicine outlines cutting-edge strategies to combat tuberculosis (TB), highlighting novel ...
However, most people get infected with TB don’t get sick, according to NCDHSS. That’s because their bodies can fight the ...
It’s also worth noting that other studies have also shown an association between the BCG vaccine, which protects against ...
Dublin, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The "BCG Vaccine Global market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology" report has been added to ...
Kansas is currently facing one the largest tuberculosis outbreaks in U.S. history with 67 confirmed active cases and 79 ...